Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways

This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essenti...

Full description

Bibliographic Details

Format:	Electronic eBook
Language:	English
Published:	Cham : Springer International Publishing, 2018.
Edition:	1st ed. 2018.
Series:	Resistance to Targeted Anti-Cancer Therapeutics, 15
Subjects:	Cancer research.
ISBN:	9783319679327
ISSN:	2196-5501 ;
Online Access:
Tags:	Add Tag No Tags, Be the first to tag this record!